PL1888013T3 - Biologicznie przyswajalne wypełniacze składające się z liposomów fosfolipidowych i kwasu hialuronowego i/lub jego pochodnych - Google Patents
Biologicznie przyswajalne wypełniacze składające się z liposomów fosfolipidowych i kwasu hialuronowego i/lub jego pochodnychInfo
- Publication number
- PL1888013T3 PL1888013T3 PL06724596T PL06724596T PL1888013T3 PL 1888013 T3 PL1888013 T3 PL 1888013T3 PL 06724596 T PL06724596 T PL 06724596T PL 06724596 T PL06724596 T PL 06724596T PL 1888013 T3 PL1888013 T3 PL 1888013T3
- Authority
- PL
- Poland
- Prior art keywords
- derivatives
- hyaluronic acid
- phospholipid liposomes
- bioresorbable
- constituted
- Prior art date
Links
- 239000000945 filler Substances 0.000 title abstract 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title abstract 2
- 229920002674 hyaluronan Polymers 0.000 title abstract 2
- 229960003160 hyaluronic acid Drugs 0.000 title abstract 2
- 239000002502 liposome Substances 0.000 title abstract 2
- 150000003904 phospholipids Chemical class 0.000 title abstract 2
- 230000007547 defect Effects 0.000 abstract 1
- 238000011065 in-situ storage Methods 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 210000004872 soft tissue Anatomy 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000146A ITPD20050146A1 (it) | 2005-05-20 | 2005-05-20 | Fillers riassorbibili costituiti da liposomi e acido ialuronico e o suoi derivati |
| PCT/EP2006/003898 WO2006122638A1 (en) | 2005-05-20 | 2006-04-21 | Bioresorbable fillers constituted by phospholipid liposomes and hyaluronic acid and/or the derivatives thereof |
| EP06724596A EP1888013B1 (en) | 2005-05-20 | 2006-04-21 | Bioresorbable fillers constituted by phospholipid liposomes and hyaluronic acid and/or the derivatives thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1888013T3 true PL1888013T3 (pl) | 2009-09-30 |
Family
ID=36734338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06724596T PL1888013T3 (pl) | 2005-05-20 | 2006-04-21 | Biologicznie przyswajalne wypełniacze składające się z liposomów fosfolipidowych i kwasu hialuronowego i/lub jego pochodnych |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8263118B2 (pl) |
| EP (1) | EP1888013B1 (pl) |
| JP (1) | JP2008540588A (pl) |
| AT (1) | ATE427731T1 (pl) |
| AU (1) | AU2006246751B2 (pl) |
| CA (1) | CA2608811C (pl) |
| DE (1) | DE602006006177D1 (pl) |
| ES (1) | ES2325420T3 (pl) |
| IT (1) | ITPD20050146A1 (pl) |
| PL (1) | PL1888013T3 (pl) |
| RU (1) | RU2394552C2 (pl) |
| WO (1) | WO2006122638A1 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1742623A (zh) * | 2005-07-13 | 2006-03-08 | 凌沛学 | 透明质酸磷脂复合物及其制备方法 |
| AU2006299421B2 (en) | 2005-10-03 | 2013-01-31 | Mark A. Pinsky | Compositions and methods for improved skin care |
| JP2008133195A (ja) * | 2006-11-27 | 2008-06-12 | Konica Minolta Holdings Inc | 水溶性薬剤内包リポソーム及びその製造方法 |
| ITMI20072348A1 (it) | 2007-12-17 | 2009-06-18 | Medichem Srl | Metodo per la rigenerazione cellulare di acido ialuronico e relativa composizione cosmetica |
| BE1018697A3 (fr) * | 2009-03-16 | 2011-07-05 | Auriga Internat | Composition cosmetique a application topique comprenant de l'acide hyaluronique. |
| IT1395392B1 (it) * | 2009-08-27 | 2012-09-14 | Fidia Farmaceutici | Geli viscoelastici come nuovi filler |
| US20130142863A1 (en) * | 2010-06-17 | 2013-06-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Phosphatidylcholine lipid liposomes as boundry lubricants in aqueous media |
| RU2473352C2 (ru) | 2011-04-21 | 2013-01-27 | Закрытое акционерное общество "Институт прикладной нанотехнологии" | Состав, имитирующий внутрисуставную жидкость, и способ получения добавки к ней |
| CN102489193B (zh) * | 2011-11-28 | 2014-06-18 | 上海景峰制药有限公司 | 一种玻璃酸钠配液过程的溶解方法 |
| US10980860B2 (en) * | 2012-10-11 | 2021-04-20 | Ascendis Pharma A/S | Diagnosis, prevention and treatment of diseases of the joint |
| TWI642440B (zh) * | 2014-04-02 | 2018-12-01 | 德商默茲製藥公司 | 含多醣之充填劑之活體降解 |
| ES2894829T3 (es) * | 2014-06-15 | 2022-02-16 | Yeda Res & Dev | Tratamiento de superficies mediante polímeros solubles en agua y lípidos/liposomas |
| CN106176632B (zh) * | 2016-08-16 | 2019-09-03 | 海南合瑞制药股份有限公司 | 一种注射用甲泼尼龙琥珀酸钠组合物 |
| ES2754476B2 (es) | 2018-10-15 | 2020-09-14 | Consejo Superior Investigacion | Gel lipidico nanoestructurado, procedimiento de preparacion y uso |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8713747D0 (en) * | 1987-06-12 | 1987-07-15 | Unilever Plc | Skin treatment composition |
| DE4322158C2 (de) * | 1993-07-03 | 1997-04-10 | Rhone Poulenc Rorer Gmbh | Phospholipidische Zusammensetzung sowie Verwendung einer derartigen Zusammensetzung |
| US5942245A (en) | 1994-11-04 | 1999-08-24 | Polymun Scientific Immunbiologische Forschung Gmbh | Application of SOD in liposomes |
| WO2001030380A2 (en) | 1999-10-27 | 2001-05-03 | K-Quay Enterprises, Llc | Methods and compositions for treatment of keratoconus using protease inhibitors |
| DE60012866T2 (de) * | 1999-12-14 | 2005-09-08 | Kibun Food Chemifa Co., Ltd. | Propylenglykolhyaluronat und äusserlich anzuwendendes Hautpflegemittel, das dieses enthält |
| WO2003000190A2 (en) * | 2001-06-25 | 2003-01-03 | Depuy | Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints |
| WO2004000671A1 (ja) * | 2002-06-20 | 2003-12-31 | Yoshino Kogyosho Co.,Ltd. | パウチ状ブロー成形容器 |
| CA2491439A1 (en) * | 2002-07-02 | 2004-01-15 | Procyte Corporation | Compositions containing peptide copper complexes and soft tissue fillers |
| CN1255671C (zh) * | 2002-08-02 | 2006-05-10 | 上海数康生物科技有限公司 | 多标志物生物芯片信号分析方法 |
| US20080010413A1 (en) | 2006-07-07 | 2008-01-10 | Krishnan Kunjunny Kailas | Method and apparatus for application-specific dynamic cache placement |
-
2005
- 2005-05-20 IT IT000146A patent/ITPD20050146A1/it unknown
-
2006
- 2006-04-21 DE DE602006006177T patent/DE602006006177D1/de active Active
- 2006-04-21 ES ES06724596T patent/ES2325420T3/es active Active
- 2006-04-21 EP EP06724596A patent/EP1888013B1/en active Active
- 2006-04-21 JP JP2008511584A patent/JP2008540588A/ja active Pending
- 2006-04-21 CA CA2608811A patent/CA2608811C/en not_active Expired - Fee Related
- 2006-04-21 PL PL06724596T patent/PL1888013T3/pl unknown
- 2006-04-21 WO PCT/EP2006/003898 patent/WO2006122638A1/en not_active Ceased
- 2006-04-21 AU AU2006246751A patent/AU2006246751B2/en not_active Ceased
- 2006-04-21 RU RU2007141864/15A patent/RU2394552C2/ru active
- 2006-04-21 AT AT06724596T patent/ATE427731T1/de active
-
2012
- 2012-02-15 US US13/397,646 patent/US8263118B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2325420T3 (es) | 2009-09-03 |
| AU2006246751B2 (en) | 2010-08-19 |
| ITPD20050146A1 (it) | 2006-11-21 |
| CA2608811A1 (en) | 2006-11-23 |
| CA2608811C (en) | 2013-11-26 |
| RU2394552C2 (ru) | 2010-07-20 |
| ATE427731T1 (de) | 2009-04-15 |
| US8263118B2 (en) | 2012-09-11 |
| DE602006006177D1 (de) | 2009-05-20 |
| RU2007141864A (ru) | 2009-06-27 |
| JP2008540588A (ja) | 2008-11-20 |
| AU2006246751A1 (en) | 2006-11-23 |
| EP1888013B1 (en) | 2009-04-08 |
| US20120148667A1 (en) | 2012-06-14 |
| EP1888013A1 (en) | 2008-02-20 |
| WO2006122638A1 (en) | 2006-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1888013T3 (pl) | Biologicznie przyswajalne wypełniacze składające się z liposomów fosfolipidowych i kwasu hialuronowego i/lub jego pochodnych | |
| BRPI0508403A (pt) | produtos de pelìcula tendo propriedades de desintegração controlada | |
| CY1118821T1 (el) | Γελες με βαση υαλουρονικο οξυ οι οποιες περιλαμβανουν αναισθητικους παραγοντες | |
| WO2009081169A3 (en) | Biodegradable contrast agents | |
| WO2010093849A3 (en) | Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions | |
| WO2007002390A3 (en) | Compositions and methods for modulation of smn2 splicing | |
| WO2009067245A3 (en) | Compositions and methods for tissue repair | |
| WO2007140312A3 (en) | Anti-cross-linking agents and methods for inhibiting cross-linking of injectable hydrogel formulations | |
| WO2006089267A3 (en) | Synthetic structure for soft tissue repair | |
| WO2007089768A3 (en) | 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them | |
| MX2018015635A (es) | Composiciones y metodos para la modulacion de division de smn2 en un sujeto. | |
| EP4616907A3 (en) | Soft tissue filler | |
| WO2012008722A3 (ko) | 조직 증강용 충전 조성물 | |
| DE102009035301A8 (de) | Verfahren zur Herstellung von Dibenz[c,e][1,2]-oxaphosphorin-Derivaten, Amino-dibenz[c,e][1,2]-oxaphosphorin sowie deren Verwendung | |
| WO2009123720A3 (en) | Methods and compositions for medical articles produced from proteinaceous compounds | |
| WO2008002683A3 (en) | Polymorphous forms of carvedilol phosphate | |
| MX2009007774A (es) | Composiciones oftalmicas que contienen una combinacion sinergistica de tres polimeros. | |
| AU2009331669A8 (en) | Dihydropyridone amides as P2X7 modulators | |
| TW200716628A (en) | Novel compounds | |
| WO2010030342A3 (en) | Heparosan polymers and methods of making and using same for the enhancement of therapeutics | |
| WO2013006671A3 (en) | Compositions and methods for spinal disc repair and other surgical and non-surgical indications | |
| WO2007133184A3 (en) | Polypeptides and biosynthetic pathways for the production of stereoisomers of monatin and their precursors | |
| GB0809592D0 (en) | Biomaterials | |
| DE602006010738D1 (de) | Pyrroloä2,3-cüpyridinderivate | |
| WO2008107471A3 (en) | Modified hydroxypolymer conjugates with killing effect on tumor cells |